The importance of studying factor V Leiden and the 20210 [correction of 29210A] allele of the prothrombin gene in thromboembolic disease
Batlle, J.; López Fernández, M.F.
Sangre 44(1): 3-6
1999
ISSN/ISBN: 0036-4355 PMID: 10323089 Document Number: 507883
Document emailed within 1 workday
Related Documents
Mandavilli, B.; Shoup, R.M.; DiGiuseppe, J.A.; Rezuke, W.N.; Tsongalis, G.J. 2000: Concurrent factor V Leiden and prothrombin G20210A gene mutations in a patient with a history of recurrent thrombosis Connecticut Medicine 64(5): 259-261Billon, S.; Escoffre-Barbe, M.; Mercier, B.; Abgrall, J.F.; Ferec, C. 1999: Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients Thrombosis and Haemostasis 81(4): 659-660
Strobel, J.; Ringwald, J.; Zimmermann, R.; Eckstein, R. 2010: Thromboembolic Risk Assessment in a Phenotypically Cured Factor-V-Leiden Carrier after Orthotopic Liver Tr ansplantation Clinical Laboratory 56(5-6): 245-247
Zuazu-Jausoro, I.; Sanchez, I.; Fernandez, M.C.; Corral, J.; Gonzalez-Conejero, R.; Vicente, V. 1998: Portal and mesenteric venous thrombosis in a patient heterozygous for the 20210 a allele of the prothrombin gene Haematologica 83(12): 1129-1130
Souto, J.C.; Coll, I.; Llobet, D.; del Río, E.; Oliver, A.; Mateo, J.; Borrell, M.; Fontcuberta, J. 1998: The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population Thrombosis and Haemostasis 80(3): 366-369
Verheggen, P.W.; Heymans, B.T.; Slagboom, P.E.; Haverkate, F.; Cats, V.M. 1997: Normal prevalence of factor V Leiden gene mutation in patients with severe unstable angina Thrombosis and Haemostasis 77(6): 1218
Narawane, N.M.; Phadke, A.Y.; Shah, S.K.; Bhandarkar, P.V.; Abraham, P. 2000: Jejunal stricture complicating acute mesenteric venous thrombosis secondary to protein C deficiency and factor V Leiden gene mutation Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 19(2): 79-80
Reuner, K.H.; Ruf, A.; Grau, A.; Rickmann, H.; Stolz, E.; Jüttler, E.; Druschky, K.F.; Patscheke, H. 1998: Prothrombin gene G20210-->A transition is a risk factor for cerebral venous thrombosis Stroke 29(9): 1765-1769
Akhavan, S.; Lavoretano, S.; Chantarangkul, V.; Mannucci, P.M. 2002: Plasma prothrombin levels are not associated with mutations in the promoter region of the prothrombin gene Thrombosis and Haemostasis 88(5): 877-878
Emmerich, J.; Rosendaal, F.R.; Cattaneo, M.; Margaglione, M.; De Stefano, V.; Cumming, T.; Arruda, V.; Hillarp, A.; Reny, J.L. 2001: Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism Thrombosis and Haemostasis 86(3): 809-816
Solodilova, M.A.; Ivanov, V.P.; Polonikov, A.V.; Khoroshaia, I.V.; Kozhukhov, M.A.; Panfilov, V.I. 2007: Heterozygosity of 198LEU mutant allele in glutathione peroxidase-1 gene as a risk factor of bronchial asthma associated with smoking Terapevticheskii Arkhiv 79(3): 33-36
Ruiz-Argüelles, G.J.; Poblete-Naredo, I.ís.; Reyes-Núñez, V.; Garcés-Eisele, J.; López-Martínez, B.; Gómez-Rangel, J.D. 2004: Primary thrombophilia in Mexico IV: frequency of the Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic Mexican Mestizo patients Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 56(5): 600-604
Kaneko, N.; Mimori, A.; Baba, S.; Nara, H.; Shirota, Y.; Nagashima, T.; Hirata, D.; Yoshio, T.; Okazaki, H.; Kano, S.; Minota, S. 2000: Rapidly progressed secondary amyloidosis in a patient with Still's disease with gamma-allele in his SAA 1 gene Ryumachi 40(3): 633-638
Tizzano, E.F.; Soria, Jé.Manuel.; Coll, I.; Guzmán, B.; Cornet, Mónica.; Altisent, C.; Martorell, M.; Domenech, M.; del Río, E.; Fontcuberta, J.; Baiget, M. 2002: The prothrombin 20210A allele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors Haematologica 87(3): 279-285
Fehmann, H.C.; Göke, B. 1994: One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma Zeitschrift für Gastroenterologie 32(7): 416-417
Bertina, R.M. 1997: Factor V Leiden and other coagulation factor mutations affecting thrombotic risk Clinical Chemistry 43(9): 1678-1683
Aksoy, M.; Tek, I.; Karabulut, H.; Berker, B.; Soylemez, F. 2005: The role of thrombofilia related to Factor V Leiden and Factor II G20210A mutations in recurrent abortions Jpma. Journal of the Pakistan Medical Association 55(3): 104-108
Cadroy, Y.; Sié, P.; Alhenc-Gelas, M.; Aiach, M. 1995: Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants Thrombosis and Haemostasis 73(4): 734-735
Eschwège, V.; Seddiki, S.; Robert, A. 1996: The tissue thromboplastin inhibition test in the detection of lupus anticoagulants: importance of a correction factor eliminating the influence of fibrinogen level Thrombosis and Haemostasis 76(1): 65-68
Bianco, I.; Lerone, M.; Foglietta, E.; Deidda, G.; Cappabianca, M.P.; Morlupi, L.; Ponzini, D.; Grisanti, P.; Di Biagio, P.; Amato, A.; Mezzabotta, M.; Graziani, B. 1997: Phenotypes of individuals with a beta thal classical allele associated either with a beta thal silent allele or with alpha globin gene triplication Haematologica 82(5): 513-525